TGFB1 and diabetic kidney disease: Since Nox4 is the major source of ROS in the kidneys during the early stages of diabetic nephropathy and in order to confirm the effect of TGFβ1 on ROS production, the levels of SOD1, which constitutes the first line of defence against ROS were determined following TGFβ1 treatment.